FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529699119> ?p ?o ?g. }

• W2529699119 endingPage "10" @default.
• W2529699119 startingPage "10" @default.
• W2529699119 abstract "The goal of this analysis was to determine the test-retest variability of functional and structural measures from a cohort of patients with advanced forms of Stargardt Disease (STGD) participating in the SAR422459 (NCT01367444) gene therapy clinical trial.Twenty-two participants, aged 24 to 66, diagnosed with advanced forms of STGD, with at least one pathogenic ABCA4 mutation on each chromosome participating in the SAR422459 (NCT01367444) gene therapy clinical trial, were screened over three visits within 3 weeks or less. Functional visual evaluations included: best-corrected visual acuity (BCVA) Early Treatment Diabetic Retinopathy Study (ETDRS) letter score, semiautomated kinetic perimetry (SKP) using isopters I4e, III4e, and V4e, hill of vision (HOV) calculated from static visual fields (SVF) by using a 184n point centrally condensed grid with the stimulus size V test target. Retinal structural changes such as central macular thickness and macular volume were assessed by spectral-domain optical coherence tomography (SD-OCT). Repeatability coefficients (RC) and 95% confidential intervals (CI) were calculated for each parameter using a hierarchical mixed-effects model and bootstrapping.Criteria for statistically significant changes for various parameters were found to be the following: BCVA letter score (8 letters), SKP isopters I4e, III4e, and V4e (3478.85; 2488.02 and 2622.46 deg2, respectively), SVF full volume HOV (VTOT, 14.62 dB-sr), central macular thickness, and macular volume (4.27 μm and 0.15 mm3, respectively).This analysis provides important information necessary to determine if significant changes are occurring in structural and functional assessments commonly used to measure disease progression in this cohort of patients with STGD. Moreover, this information is useful for future trials assessing safety and efficacy of treatments in STGD.Determination of variability of functional and structural measures in participants with advanced stages of the STGD is necessary to assess efficacy and safety in treatment trials involving STGD patients." @default.
• W2529699119 created "2016-10-14" @default.
• W2529699119 creator A5000106305 @default.
• W2529699119 creator A5006652347 @default.
• W2529699119 creator A5021422523 @default.
• W2529699119 creator A5023831605 @default.
• W2529699119 creator A5025905999 @default.
• W2529699119 creator A5033019802 @default.
• W2529699119 creator A5036422156 @default.
• W2529699119 creator A5049648327 @default.
• W2529699119 creator A5055701147 @default.
• W2529699119 creator A5056837136 @default.
• W2529699119 creator A5063215739 @default.
• W2529699119 creator A5068520233 @default.
• W2529699119 creator A5077263714 @default.
• W2529699119 creator A5083982156 @default.
• W2529699119 date "2016-10-01" @default.
• W2529699119 modified "2023-10-14" @default.
• W2529699119 title "Test–Retest Variability of Functional and Structural Parameters in Patients with Stargardt Disease Participating in the SAR422459 Gene Therapy Trial" @default.
• W2529699119 cites W1509208965 @default.
• W2529699119 cites W1543130240 @default.
• W2529699119 cites W173109499 @default.
• W2529699119 cites W1964753793 @default.
• W2529699119 cites W1977847843 @default.
• W2529699119 cites W1989611768 @default.
• W2529699119 cites W1991544676 @default.
• W2529699119 cites W2005431409 @default.
• W2529699119 cites W2005970825 @default.
• W2529699119 cites W2009566839 @default.
• W2529699119 cites W2018318121 @default.
• W2529699119 cites W2026892598 @default.
• W2529699119 cites W2050367139 @default.
• W2529699119 cites W2063904305 @default.
• W2529699119 cites W2065057372 @default.
• W2529699119 cites W2075715487 @default.
• W2529699119 cites W2077602259 @default.
• W2529699119 cites W2078280403 @default.
• W2529699119 cites W2082246284 @default.
• W2529699119 cites W2082541003 @default.
• W2529699119 cites W2121918635 @default.
• W2529699119 cites W2129572698 @default.
• W2529699119 cites W2130848396 @default.
• W2529699119 cites W2144184852 @default.
• W2529699119 cites W2147560227 @default.
• W2529699119 cites W2156214239 @default.
• W2529699119 cites W2188128522 @default.
• W2529699119 cites W2305359735 @default.
• W2529699119 cites W2335550476 @default.
• W2529699119 cites W2344435438 @default.
• W2529699119 cites W4214688168 @default.
• W2529699119 cites W832904095 @default.
• W2529699119 doi "https://doi.org/10.1167/tvst.5.5.10" @default.
• W2529699119 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5054761" @default.
• W2529699119 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27730010" @default.
• W2529699119 hasPublicationYear "2016" @default.
• W2529699119 type Work @default.
• W2529699119 sameAs 2529699119 @default.
• W2529699119 citedByCount "35" @default.
• W2529699119 countsByYear W25296991192017 @default.
• W2529699119 countsByYear W25296991192018 @default.
• W2529699119 countsByYear W25296991192019 @default.
• W2529699119 countsByYear W25296991192020 @default.
• W2529699119 countsByYear W25296991192021 @default.
• W2529699119 countsByYear W25296991192022 @default.
• W2529699119 crossrefType "journal-article" @default.
• W2529699119 hasAuthorship W2529699119A5000106305 @default.
• W2529699119 hasAuthorship W2529699119A5006652347 @default.
• W2529699119 hasAuthorship W2529699119A5021422523 @default.
• W2529699119 hasAuthorship W2529699119A5023831605 @default.
• W2529699119 hasAuthorship W2529699119A5025905999 @default.
• W2529699119 hasAuthorship W2529699119A5033019802 @default.
• W2529699119 hasAuthorship W2529699119A5036422156 @default.
• W2529699119 hasAuthorship W2529699119A5049648327 @default.
• W2529699119 hasAuthorship W2529699119A5055701147 @default.
• W2529699119 hasAuthorship W2529699119A5056837136 @default.
• W2529699119 hasAuthorship W2529699119A5063215739 @default.
• W2529699119 hasAuthorship W2529699119A5068520233 @default.
• W2529699119 hasAuthorship W2529699119A5077263714 @default.
• W2529699119 hasAuthorship W2529699119A5083982156 @default.
• W2529699119 hasBestOaLocation W25296991191 @default.
• W2529699119 hasConcept C104317684 @default.
• W2529699119 hasConcept C118487528 @default.
• W2529699119 hasConcept C119767625 @default.
• W2529699119 hasConcept C127716648 @default.
• W2529699119 hasConcept C2778257484 @default.
• W2529699119 hasConcept C2779460726 @default.
• W2529699119 hasConcept C2780604041 @default.
• W2529699119 hasConcept C2780827179 @default.
• W2529699119 hasConcept C54355233 @default.
• W2529699119 hasConcept C71924100 @default.
• W2529699119 hasConcept C86803240 @default.
• W2529699119 hasConceptScore W2529699119C104317684 @default.
• W2529699119 hasConceptScore W2529699119C118487528 @default.
• W2529699119 hasConceptScore W2529699119C119767625 @default.
• W2529699119 hasConceptScore W2529699119C127716648 @default.
• W2529699119 hasConceptScore W2529699119C2778257484 @default.
• W2529699119 hasConceptScore W2529699119C2779460726 @default.
• W2529699119 hasConceptScore W2529699119C2780604041 @default.

• next